AFN-4801

N/A

Report date: 2026/04/23 17:58:01

Base Information

Drug NameAFN-4801

Drug Alias NameAFN-4801

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy > Dual-target CAR-T cell therapyCell and gene therapy > Gene therapy > mRNACell and gene therapy > Cell therapy > Donor > Autologous +[4]

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsN/A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusClinical

Highest Status in ChinaClinical

Originator CompaniesHefei Afana Biotechnology Co Ltd

China Registration ClassN/A

Develop Information

Active CompaniesHefei Afana Biotechnology Co Ltd

Inactive CompaniesN/A

Active IndicationsN/A

Inactive IndicationsN/A

Other Information

ATC CodeN/A